Brief: Emmaus Life Sciences Announces The Sale Of Its Telcon Rf Pharmaceutical Inc. Shares
14/10/2020 19:03
Oct 14 (Reuters) - Emmaus Life Sciences Inc EMMA.PK :
* PRESS RELEASE - EMMAUS LIFE SCIENCES ANNOUNCES THE SALE OF
ITS
TELCON RF PHARMACEUTICAL INC. SHARES
* SOLD ALL REMAINING COMMON SHARES OF SOUTH KOREA-BASED
TELCON RF
PHARMACEUTICAL INC
Source text for Eikon: urn:newsml:reuters.com:*:nPn4jd0SRa
Further company coverage: EMMA.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Telcon RF Pharmaceutical
See all newsBrief: Telcon Rf Pharmaceutical To Conduct Capital Increase Of 28 Billion Won
Brief: Telcon Rf Pharmaceutical Inc To Acquire 10 Billion Won Worth Of Shares In Abion Inc
Brief: Telcon Rf Pharmaceutical To Acquire 16 Billion Won Worth Of Shares In Abion Inc
Brief: Humanigen Executes Licensing Agreement For Lenzilumab In Covid-19 With KPM Tech/Telcon RF Pharmaceutical For South Korea And The Philippines
Brief: Emmaus Life Sciences Announces The Sale Of Its Telcon Rf Pharmaceutical Inc. Shares